Indications for Intestinal Transplantation.
Indications
Intestine
Pre-emptive
Transplant
Journal
Gastroenterology clinics of North America
ISSN: 1558-1942
Titre abrégé: Gastroenterol Clin North Am
Pays: United States
ID NLM: 8706257
Informations de publication
Date de publication:
Jun 2024
Jun 2024
Historique:
medline:
9
5
2024
pubmed:
9
5
2024
entrez:
8
5
2024
Statut:
ppublish
Résumé
Outcomes for patients with chronic intestinal failure have improved with organization of experts into multidisciplinary teams delivering care in intestinal rehabilitation programs. There have been improvements in understanding of intestinal failure complications as well as development of newer therapies that have amplified the improvements in survival. In spite of this encouraging trend, patients who fail PN are often referred too late for intestinal transplantation. The author proposes a more rational framework that might allow earlier identification of intestinal failure patients at risk for PN-failure, who could appropriately be considered earlier for intestinal transplantation with improvements in overall outcomes.
Identifiants
pubmed: 38719375
pii: S0889-8553(24)00009-8
doi: 10.1016/j.gtc.2024.02.001
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
233-244Informations de copyright
Copyright © 2024 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure K.R. Iyer is a Scientific advisor and Consultant at Ironwood Pharmaceuticals and a Scientific advisor at Northsea Therapeutics and Hanmi Pharmaceuticals. K.R. Iyer received Grant support from Ironwood Pharmaceuticals, Takeda Pharmaceuticals, Northsea Therapeutics, and Hanmi Pharmaceuticals.